Cargando…
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
Direct-acting antivirals (DAA) have revolutionized the treatment of patients with chronic hepatitis C virus (HCV) infection, possibly leading to HCV elimination by 2030 as endorsed by the World Health Organization (WHO). However, some patients belonging to the so-called unique or special populations...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228389/ https://www.ncbi.nlm.nih.gov/pubmed/34205966 http://dx.doi.org/10.3390/v13061048 |